Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer (Journal of Experimental & Clinical Cancer Research, (2016), 35, 1, (99), 10.1186/s13046-016-0372-5)

Following publication of the original article [1], author found errors in Fig. 7, specifically: Fig. 7d – the result of flow cytometry assay in Tet-shRNA + Dox group was misplaced Fig. 7f – the results of flow cytometry assay in Tet-shRNA –Dox group and Tet-NC–Dox group were misplaced (Figure presented.) Fig. 7d – the result of flow cytometry assay in Tet-shRNA + Dox group was misplaced Fig. 7f – the results of flow cytometry assay in Tet-shRNA –Dox group and Tet-NC–Dox group were misplaced Transfection with si-HOXD-AS1 or tet shRNA induced apoptosis in 5637 and T24. a-c The rate of early apoptotic 5637 (P = 0.001) and T24 cells (P < 0.001) were increased significantly after transfection with si-HOXD-AS1. d-g Increased apoptotic cells were observed in tet-shRNA-transfected 5637 (P = 0.001) and T24 cells (P < 0.001). Results represent the mean ± SD from three independent experiments The corrected Fig. 7 is given here. The correction does not affect the conclusions of the article.